| Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization | New England Journal of Medicine | 1997 | 1.5K |
| Coronary artery anomalies in 126,595 patients undergoing coronary arteriography | Catheterization and Cardiovascular Diagnosis | 1990 | 1.4K |
| Heart-rate recovery immediately after exercise as a predictor of mortality | New England Journal of Medicine | 1999 | 1.3K |
| Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling | Circulation Research | 2001 | 1.1K |
| Prevalence of conventional risk factors in patients with coronary heart disease | JAMA - Journal of the American Medical Association | 2003 | 950 |
| Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention | Circulation | 1998 | 887 |
| New Doppler echocardiographic applications for the study of diastolic function | Journal of the American College of Cardiology | 1998 | 820 |
| Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST) | Circulation | 2001 | 781 |
| Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators | Lancet, The | 1994 | 775 |
| Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease | Circulation | 1995 | 751 |
| Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation | New England Journal of Medicine | 2001 | 736 |
| Color M-mode Doppler flow propagation velocity is a preload insensitive index of left ventricular relaxation: animal and human validation | Journal of the American College of Cardiology | 2000 | 695 |
| Profile and prevalence of aspirin resistance in patients with cardiovascular disease | American Journal of Cardiology | 2001 | 672 |
| Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine | New England Journal of Medicine | 1995 | 665 |
| Prospects for in vivo Raman spectroscopy | Physics in Medicine and Biology | 2000 | 649 |
| Recognition of the importance of embolization in atherosclerotic vascular disease | Circulation | 2000 | 634 |
| Unexpected abrupt increase in left ventricular assist device thrombosis | New England Journal of Medicine | 2014 | 615 |
| A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group | New England Journal of Medicine | 1993 | 590 |
| Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2 | Proceedings of the National Academy of Sciences of the United States of America | 2003 | 569 |
| Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization | New England Journal of Medicine | 2001 | 555 |
| Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging | European Heart Journal Cardiovascular Imaging | 2015 | 541 |
| Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade | Lancet, The | 1998 | 538 |
| Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation | Circulation | 2001 | 526 |
| Cause of death in clinical research: time for a reassessment? | Journal of the American College of Cardiology | 1999 | 493 |
| High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound | Circulation | 2001 | 485 |
